Marcus Branschädel

APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fcγ Receptors

Christian Gieffers, Michael Kluge, Christian J. Merz et al. · Molecular Cancer Therapeutics · 2013 · 109 citations · Full text

Cell Death, Cancer Biology, Signaling Pathway +19

The Tumor Necrosis Factor Receptor Stalk Regions Define Responsiveness to Soluble versus Membrane-Bound Ligand

C. Richter, Sylvia K. E. Messerschmidt, Gerlinde Holeiter et al. · Molecular and Cellular Biology · 2012 · 62 citations · Full text

Proteinlipid Interaction, Soluble Tnf, Versus Membrane-bound Ligand +23

A Humanized Tumor Necrosis Factor Receptor 1 (TNFR1)-specific Antagonistic Antibody for Selective Inhibition of Tumor Necrosis Factor (TNF) Action

Roland E. Kontermann, Sabine Münkel, Dafne Müller et al. · Journal of Immunotherapy · 2008 · 44 citations

Membrane Environment Reduces the Accessible Conformational Space Available to an Integral Membrane Protein

Uwe Gerken, Fedor Jelezko, Britta Götze et al. · The Journal of Physical Chemistry B · 2002 · 43 citations

Membrane Structure, Proteinlipid Interaction, Protein Assembly +16

Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2

Verena Boschert, Anja Krippner‐Heidenreich, Marcus Branschädel et al. · Cellular Signalling · 2010 · 40 citations

Signal Transduction, Signaling Pathway, G Protein-coupled Receptor +10